Subtype
Oropharyngeal Neoplasm
CI-CAN-00003505Explore in graph →
Non-malignant147 active trials2 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003505Explore in graph →
Clinical trials
487 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05696314 | Surgeon-performed Outpatient Transoral and Transcervical Ultrasound of the Oropharynx(SPOT-US) | completed | N/A | 201 | Rigshospitalet, DenmarkOTHER | 1 | Oct 3, 2024 | clinicaltrials |
| NCT02258659 | Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer(OPTIMA) | completed | Phase 2 | 62 | University of ChicagoOTHER | 1 |
| Sep 24, 2024 |
| clinicaltrials |
| NCT06314711 | Ex Vivo 3D-ultrasound for Oropharyngeal Cancer | completed | N/A | 15 | Rigshospitalet, DenmarkOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT03422536 | Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma | completed | Phase 2 | 78 | University of ArizonaOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT01847326 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer | completed | Phase 1 | 48 | University of ChicagoOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT01064479 | Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 123 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT04541355 | Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin | completed | Phase 2 | 16 | Hyunseok Kang, MDOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT02072148 | The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) | completed | N/A | 112 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03077243 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | completed | Phase 2 | 195 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT04567082 | Proteome- and Methylation Profiles in Oropharyngeal Cancer(PROMEO) | completed | — | 45 | Aalborg University HospitalOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT02703493 | Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer | completed | N/A | 39 | Northwell HealthOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT02757222 | Dose Escalation Versus Standard in Laryngopharyngeal Cancers(INTELHOPE) | completed | N/A | 100 | Tata Medical CenterOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT05368025 | Staying Connected: a Mobile Health Study With the Noona® and Mobili-T® Systems | completed | — | 65 | University of AlbertaOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT04572100 | Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer | completed | Phase 1 | 50 | University of ChicagoOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT01935921 | Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer | completed | Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2023 | clinicaltrials |
| NCT01711541 | Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 7, 2023 | clinicaltrials |
| NCT03418792 | Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx | completed | N/A | 40 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05698667 | Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer | completed | N/A | 26 | Rigshospitalet, DenmarkOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT04112940 | Physiological Flow of Liquids in Head and Neck Cancer Patients: A Pilot Study | completed | — | 12 | University Health Network, TorontoOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT03427411 | M7824 in Subjects With HPV Associated Malignancies | completed | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04189107 | Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS | completed | Phase 3 | 18 | Rigshospitalet, DenmarkOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT03032250 | Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer | completed | N/A | 35 | Wake Forest University Health SciencesOTHER | 1 | Jan 9, 2023 | clinicaltrials |
| NCT03342378 | PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients | completed | — | 24 | University of Wisconsin, MadisonOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT01088802 | Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx | completed | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT02002182 | ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer | completed | Phase 2 | 15 | Andrew SikoraOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT03448341 | Dysphagia Assessment After Swallowing Sparing RadioTherapy(DASRT) | completed | — | 74 | Azienda Ospedaliero, Universitaria PisanaOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT01265849 | Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity(IT-MATTERS) | completed | Phase 3 | 928 | CEL-SCI CorporationINDUSTRY | 23 | Aug 19, 2022 | clinicaltrials |
| NCT03148665 | Saliva-based Detection of CD44(Detect 44) | completed | — | 85 | Joseph CalifanoOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT05299957 | Usefulness of Integrated PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation | completed | — | 233 | Chang Gung Memorial HospitalOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT02775812 | Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2022 | clinicaltrials |
| NCT01884259 | Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN(HNO-2) | completed | Phase 2 | 100 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | May 26, 2022 | clinicaltrials |
| NCT00964977 | Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. | completed | Phase 3 | 209 | Johannes Gutenberg University MainzOTHER | 3 | Feb 25, 2022 | clinicaltrials |
| NCT03269344 | Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer | completed | Phase 3 | 65 | Henry Ford Health SystemOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT03096808 | Adaptive Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT01816984 | PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 12 | University of ChicagoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04189003 | Molecular Signatures of HPV+ ORL Cancers (OROPAP)(OROPAP) | completed | — | 66 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT05025618 | Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME)(ARTOME) | completed | — | 132 | Center Eugene MarquisOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02981862 | CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas(CaptHPV) | completed | N/A | 100 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT02736786 | A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal Tumors | completed | — | 64 | Mayo ClinicOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT01173692 | Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study. | completed | Phase 2 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 20, 2021 | clinicaltrials |
| NCT03239834 | Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making | completed | — | 893 | Vigilant Biosciences, Inc.INDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT01874587 | Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma(ARTIX) | completed | Phase 3 | 132 | Center Eugene MarquisOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT01084733 | Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer | completed | — | 115 | Mahesh KudrimotiOTHER | 1 | Jul 14, 2021 | clinicaltrials |
| NCT02405000 | Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance | completed | N/A | 23 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 23, 2021 | clinicaltrials |
| NCT03144778 | Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer | completed | Phase 1 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT00084682 | Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02412241 | Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients | completed | N/A | 118 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 3, 2021 | clinicaltrials |
| NCT03435471 | Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck Cancer | completed | N/A | 30 | University of MiamiOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT01663259 | Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients | completed | N/A | 43 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 19, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Oct 3, 2024source: clinicaltrials